Zivo Bioscience Inc (ZIVO) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Zivo Bioscience Inc (ZIVO) has a cash flow conversion efficiency ratio of 0.081x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-266.56K) by net assets ($-3.29 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Zivo Bioscience Inc - Cash Flow Conversion Efficiency Trend (2003–2024)
This chart illustrates how Zivo Bioscience Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Zivo Bioscience Inc balance sheet liabilities for a breakdown of total debt and financial obligations.
Zivo Bioscience Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zivo Bioscience Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ata Gayrimenkul Yatirim Ortakligi AS
IS:ATAGY
|
-0.002x |
|
Tong Hua Holding Public Company Limited
BK:TH
|
0.002x |
|
Maming Enam Sembilan Mineral Tbk PT
JK:AKSI
|
-0.008x |
|
Churchill Capital Corp IX Warrant
NASDAQ:CCIXW
|
-0.001x |
|
Waja Konsortium Bhd
KLSE:0102
|
-0.118x |
|
Huize Holding Ltd
NASDAQ:HUIZ
|
-0.198x |
|
Quantum BioPharma Ltd.
NASDAQ:QNTM
|
-0.229x |
|
Financiere Marjos SA
PA:FINM
|
0.147x |
Annual Cash Flow Conversion Efficiency for Zivo Bioscience Inc (2003–2024)
The table below shows the annual cash flow conversion efficiency of Zivo Bioscience Inc from 2003 to 2024. For the full company profile with market capitalisation and key ratios, see ZIVO stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-514.90K | $-4.31 Million | 8.377x | +218.61% |
| 2023-12-31 | $-2.21 Million | $-5.80 Million | 2.629x | -99.61% |
| 2022-12-31 | $-10.62K | $-7.10 Million | 668.670x | +59486.24% |
| 2021-12-31 | $6.04 Million | $-6.80 Million | -1.126x | -592.01% |
| 2020-12-31 | $-11.31 Million | $-2.59 Million | 0.229x | -48.53% |
| 2019-12-31 | $-8.34 Million | $-3.71 Million | 0.445x | +97.87% |
| 2018-12-31 | $-22.28 Million | $-5.01 Million | 0.225x | -13.66% |
| 2017-12-31 | $-16.30 Million | $-4.24 Million | 0.260x | +39.36% |
| 2016-12-31 | $-13.62 Million | $-2.54 Million | 0.187x | -22.79% |
| 2015-12-31 | $-9.50 Million | $-2.30 Million | 0.242x | -43.70% |
| 2014-12-31 | $-6.37 Million | $-2.74 Million | 0.430x | +38.01% |
| 2013-12-31 | $-9.59 Million | $-2.99 Million | 0.311x | -30.56% |
| 2012-12-31 | $-3.96 Million | $-1.77 Million | 0.448x | -29.64% |
| 2011-12-31 | $-2.03 Million | $-1.29 Million | 0.637x | -57.89% |
| 2010-12-31 | $-951.68K | $-1.44 Million | 1.513x | +397.95% |
| 2009-12-31 | $-3.79 Million | $-1.15 Million | 0.304x | -83.13% |
| 2008-12-31 | $-519.60K | $-935.82K | 1.801x | -3.29% |
| 2007-12-31 | $-755.37K | $-1.41 Million | 1.862x | -25.79% |
| 2006-12-31 | $-832.54K | $-2.09 Million | 2.510x | -10.22% |
| 2005-12-31 | $-590.09K | $-1.65 Million | 2.795x | +140.67% |
| 2004-12-31 | $-1.10 Million | $-1.28 Million | 1.161x | +139.94% |
| 2003-12-31 | $-35.94K | $-17.39K | 0.484x | -- |
About Zivo Bioscience Inc
ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically act… Read more